[Pharmacologic and therapeutic perspectives on calcium inhibitors].
D000818:Animals; D001808:Blood Vessels / Q000187:drug effects*; D002118:Calcium / Q000378:metabolism; D002121:Calcium Channel Blockers / Q000494:pharmacology* / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D002463:Cell Membrane Permeability / Q000187:drug effects; D003331:Coronary Vessels / Q000187:drug effects; D006321:Heart / Q000187:drug effects*; D006801:Humans; D007473:Ion Channels / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000378:metabolism; D009200:Myocardial Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism; D051381:Rats; D014661:Vasoconstriction / Q000187:drug effects
D002121:Calcium Channel Blockers; D007473:Ion Channels; D002118:Calcium
Perspectives pharmacologiques et thérapeutiques des inhibiteurs calciques.